Count Me GRIN 2020

Share This Post

CureGRIN is looking for 100 GRIN Champions to help us raise $250,000 to fund research for a cure for GRIN Disorder.

Researchers agree that a cure for GRIN Disorder is possible, but WE NEED YOUR HELP! The momentum and knowledge our GRIN Community is building is truly remarkable and leaves us even more hopeful that we will find a cure for our GRIN loved ones someday.

We really need your help this year. 2020 was the year we had planned to ramp up our fundraising campaigns with in-person events such as with golf tournaments and galas. Sadly, the global pandemic has crushed those plans. Now, more than ever, WE NEED YOUR HELP to push forward our research efforts.

We are grateful for your support in raising $2,500 from family, friends and other contacts. Don’t worry if you do not actually meet the $2,500 goal. Even to come close is a huge accomplishment. Everything helps bring us closer to finding a cure. Thanks to the generous support from Chan Zuckerberg Initiative’s Rare as One program, we are able to ensure that one hundred percent of funds raised during this years’ Count Me GRIN campaign will go directly to priorities through a research strategy we are developing with parents, researchers and clinicians.

Starting November 1st, we will kickoff our 2nd Count Me GRIN campaign. As a GRIN Champion, you can set up a personalized fundraiser page with your kid’s story and picture. We will give you instructions and everything you need to participate.

Our goal is to find cures and therapies for GRIN Disorder as quickly as possible. Can we count on you to say, “Count Me GRIN”?

Ready to get Started?

 

Read more Posts

News

How 2023 brought us closer to treatments and cures

Since our founding in 2019, CureGRIN has been working tirelessly alongside researchers, clinicians and industry to accelerate the path to treatments and cures. There are many promising compounds and genetic treatments, but there are barriers in getting those to clinical trial. Adding ICD-10 codes for these nine genes would remove a significant barrier to clinical trials, by helping us to better understand where our patients are located.

Skip to content